1. Executive summary |
2. Global Liquid Biopsy Market Introduction |
2.1. Global Liquid Biopsy Market – Taxonomy |
2.2. Global Liquid Biopsy Market –Definitions |
2.2.1. By Product Type |
2.2.2. By Application Type |
2.2.3. By Sample Type |
2.2.4. By End User |
3. Global Liquid Biopsy Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Liquid Biopsy Market Dynamics – Factors Impact Analysis |
3.6. Global Liquid Biopsy Market – Regulations |
3.6.1. U.S. |
3.6.2. Europe |
3.7. Federal Grants for Liquid Biopsy Startups |
3.8. Venture Capital Investments in Liquid Biopsy Companies |
3.9. Product Innovations |
3.10. Startups working in the Liquid Biopsy |
3.11. Novel Applications of Liquid Biopsy |
4. Global Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Liquid Biopsy Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 |
5.1. Consumables |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Instruments |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Liquid Biopsy Market, By Sample Type, 2017 – 2021 and Forecast, 2022 – 2028 |
6.1. Blood |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Urine |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3. Others |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7. Global Liquid Biopsy Market Forecast, By Application Type, 2017 – 2021 and Forecast, 2022 – 2028 |
7.1. Lung Cancer |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Breast Cancer |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Colorectal Cancer |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Prostate Cancer |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Liver Cancer |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Liquid Biopsy Market Forecast, By End User Type, 2017 – 2021 and Forecast, 2022 – 2028 |
8.1. Hospitals |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Diagnostic Laboratories |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Academic and Research Centers |
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Liquid Biopsy Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 |
9.1. North America |
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, Sample Type, End User, and Region, 2022 – 2028 |
10. North America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
10.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Consumables |
10.1.2. Instruments |
10.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Blood |
10.2.2. Urine |
10.2.3. Others |
10.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Lung Cancer |
10.3.2. Breast Cancer |
10.3.3. Colorectal Cancer |
10.3.4. Prostate Cancer |
10.3.5. Liver Cancer |
10.3.6. Others |
10.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Hospitals |
10.4.2. Diagnostic Laboratories |
10.4.3. Academic and Research Centers |
10.4.4. Others |
10.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. U.S. |
10.5.2. Canada |
10.6. North America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028 |
10.7. North America Liquid Biopsy Market Dynamics – Trends |
11. Europe Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
11.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Consumables |
11.1.2. Instruments |
11.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Blood |
11.2.2. Urine |
11.2.3. Others |
11.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Lung Cancer |
11.3.2. Breast Cancer |
11.3.3. Colorectal Cancer |
11.3.4. Prostate Cancer |
11.3.5. Liver Cancer |
11.3.6. Others |
11.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Hospitals |
11.4.2. Diagnostic Laboratories |
11.4.3. Academic and Research Centers |
11.4.4. Others |
11.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Holland |
11.5.9. Rest of Europe |
11.6. Europe Liquid Biopsy Market – Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028 |
11.7. Europe Liquid Biopsy Market Dynamics – Trends |
12. Asia-Pacific Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
12.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Consumables |
12.1.2. Instruments |
12.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Blood |
12.2.2. Urine |
12.2.3. Others |
12.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Lung Cancer |
12.3.2. Breast Cancer |
12.3.3. Colorectal Cancer |
12.3.4. Prostate Cancer |
12.3.5. Liver Cancer |
12.3.6. Others |
12.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Hospitals |
12.4.2. Diagnostic Laboratories |
12.4.3. Academic and Research Centers |
12.4.4. Others |
12.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028 |
12.7. Asia-Pacific Liquid Biopsy Market Dynamics – Trends |
13. Latin America Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
13.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Consumables |
13.1.2. Instruments |
13.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Blood |
13.2.2. Urine |
13.2.3. Others |
13.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Lung Cancer |
13.3.2. Breast Cancer |
13.3.3. Colorectal Cancer |
13.3.4. Prostate Cancer |
13.3.5. Liver Cancer |
13.3.6. Others |
13.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Hospitals |
13.4.2. Diagnostic Laboratories |
13.4.3. Academic and Research Centers |
13.4.4. Others |
13.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Argentina |
13.5.4. Venezuela |
13.5.5. Rest of Latin America |
13.6. Latin America Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028 |
13.7. Latin America Liquid Biopsy Market Dynamics – Trends |
14. Middle East and Africa Liquid Biopsy Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 |
14.1. By Product Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Consumables |
14.1.2. Instruments |
14.2. By Sample Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Blood |
14.2.2. Urine |
14.2.3. Others |
14.3. Application Type Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Lung Cancer |
14.3.2. Breast Cancer |
14.3.3. Colorectal Cancer |
14.3.4. Prostate Cancer |
14.3.5. Liver Cancer |
14.3.6. Others |
14.4. End User Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Hospitals |
14.4.2. Diagnostic Laboratories |
14.4.3. Academic and Research Centers |
14.4.4. Others |
14.5. Country Analysis (2017 – 2021) and Forecast (2022 – 2028) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA Liquid Biopsy Market – Opportunity Analysis Index, By Product Type, By Application Type, By Sample Type, End User and Country, 2022 – 2028 |
14.7. MEA Liquid Biopsy Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Catabasis Pharmaceuticals Inc. |
15.2.2. NS Pharma, Inc |
15.2.3. Marathon Pharmaceuticals, LLC |
15.2.4. ITALFARMACO S.p.A. |
15.2.5. FibroGen, Inc. |
15.2.6. Summit Therapeutics plc |
15.2.7. PTC Therapeutics |
15.2.8. Santhera Pharmaceuticals |
15.2.9. Sarepta Therapeutics, Inc. |
16. Research Methodology |
17. Key Assumptions and Acronyms |